Australian data and meta-analysis lend support for alpha-synuclein (NACP-Rep1) as a risk factor for Parkinson's disease
Contribuinte(s) |
M. Zimmermann |
---|---|
Data(s) |
01/01/2005
|
Resumo |
It remains unclear whether genetic variants in SNCA (the alpha-synuclein gene) alter risk for sporadic Parkinson's disease (PD). The polymorphic mixed sequence repeat (NACP-Rep I) in the promoter region of SNCA has been previously examined as a potential susceptibility factor for PD with conflicting results. We report genotype and allele distributions at this locus from 369 PD cases and 370 control subjects of European Australian ancestry, with alleles designated as -1, 0, +1, +2, and +3 as previously described. Allele frequencies designated (0) were less common in Australian cases compared to controls (OR = 0.80, 95% CI 0.62-1.03). Combined analysis including all previously published ancestral European Rep1 data yielded a highly significant association between the 0 allele and a reduced risk for PD (OR = 0.79, 95% CI 0.70-0.89, p = 0.0001). Further study must now proceed to examine in detail this interesting and biologically plausible genetic association. (C) 2004 Elsevier Ireland Ltd. All rights reserved. |
Identificador | |
Idioma(s) |
eng |
Publicador |
Elsevier Ireland |
Palavras-Chave | #Neurosciences #Alpha-synuclein #Parkinson's Disease #Meta-analysis #Allelic Variation #Gene #Polymorphism #Susceptibility #Haplotypes #Mutation #Transcription #Genotype #C1 #321013 Neurology and Neuromuscular Diseases #730104 Nervous system and disorders |
Tipo |
Journal Article |